Methoxamine O
evoked O
non O
- O
significant O
increases O
in O
MUP O
and O
diastolic O
blood O
pressure O
but O
caused O
a B
significant I
rise I
in I
systolic I
blood I
pressure I
and O
significant O
fall O
in O
heart O
rate O
at O
maximum O
dosage O
. O

Hyponatremia B
and O
syndrome B
of I
inappropriate I
anti I
- I
diuretic I
hormone I
reported O
with O
the O
use O
of O
Vincristine O
: O
an O
over O
- O
representation O
of O
Asians O
? O

Persistent O
sterile O
leukocyturia B
is O
associated O
with O
impaired B
renal I
function I
in O
human B
immunodeficiency I
virus I
type I
1 I
- I
infected I
children O
treated O
with O
indinavir O
. O

DESIGN O
: O
A O
prospective O
study O
to O
monitor O
indinavir O
- O
related O
nephrotoxicity B
in O
a O
cohort O
of O
30 O
human B
immunodeficiency I
virus I
type I
1 I
- I
infected I
children O
treated O
with O
indinavir O
. O

METHOD O
: O
Thirteen O
patients O
who O
developed O
optic B
neuropathy I
after O
being O
treated O
with O
ethambutol O
for O
tuberculosis B
of I
the I
lung I
or I
lymph I
node I
at O
Siriraj O
Hospital O
between O
1997 O
and O
2001 O
were O
retrospectively O
reviewed O
. O

Syndrome B
of I
inappropriate I
secretion I
of I
antidiuretic I
hormone I
after O
infusional O
vincristine O
. O

Evaluation O
revealed O
the O
syndrome B
of I
inappropriate I
secretion I
of I
antidiuretic I
hormone I
, O
which O
was O
attributed O
to O
the O
vincristine O
infusion O
. O

BACKGROUND O
: O
Treatment O
options O
are O
scarce O
in O
pretreated O
advanced O
non B
- I
small I
- I
cell I
lung I
cancer I
( O
NSCLC B
) O
patients O
. O

METHOD O
: O
We O
retrospectively O
evaluated O
the O
medical O
records O
of O
205 O
consecutive O
adult O
patients O
who O
underwent O
full O
- O
size O
liver O
transplantation O
between O
January O
2006 O
and O
December O
2010 O
due O
to O
end B
- I
stage I
or I
malignant I
liver I
disease I
. O

OBJECTIVE O
: O
To O
report O
a O
case O
of O
syndrome B
of I
inappropriate I
anti I
- I
diuretic I
hormone I
( O
SIADH B
) O
secretion O
associated O
with O
desvenlafaxine O
. O

After O
one O
week O
of O
therapy O
, O
he O
was O
transferred O
to O
the O
intensive O
care O
unit O
with O
cardiopulmonary O
compromise O
related O
to O
superior B
vena I
cava I
( I
SVC I
) I
syndrome I
. O

Alternating B
sinus I
rhythm I
and O
intermittent O
sinoatrial B
( I
S I
- I
A I
) I
block I
was O
observed O
in O
a O
57 O
- O
year O
- O
old O
woman O
, O
under O
treatment O
for O
angina B
with O
80 O
mg O
propranolol O
daily O
. O

Nefiracetam O
is O
a O
novel O
pyrrolidone O
derivative O
which O
attenuates O
scopolamine O
- O
induced O
learning B
and I
post I
- I
training I
consolidation I
deficits I
. O

CONCLUSIONS O
: O
In O
humans O
, O
the O
intracoronary O
infusion O
of O
cocaine O
sufficient O
in O
amount O
to O
achieve O
a O
high O
drug O
concentration O
in O
coronary O
sinus O
blood O
causes O
a O
deterioration B
of I
LV I
systolic I
and I
diastolic I
performance I
. O

